Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd
688336
Company Profile
Business description
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
Contact
No.399 Libing Road
China (Shanghai) Pilot Free Trade Zone
Shanghai201203
CHNT: +86 2150791399
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
995
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,648.80 | 198.80 | -2.53% |
| CAC 40 | 7,017.50 | 257.45 | -3.54% |
| DAX 40 | 20,010.11 | 631.61 | -3.06% |
| Dow JONES (US) | 37,822.40 | 2,723.53 | -6.72% |
| FTSE 100 | 7,802.51 | 252.47 | -3.13% |
| HKSE | 20,223.57 | 2,626.24 | -11.49% |
| NASDAQ | 15,556.05 | 994.56 | -6.01% |
| Nikkei 225 | 33,030.66 | 749.92 | -2.22% |
| NZX 50 Index | 11,922.90 | 302.38 | -2.47% |
| S&P 500 | 5,041.94 | 32.14 | -0.63% |
| S&P/ASX 200 | 7,451.20 | 216.60 | -2.82% |
| SSE Composite Index | 3,120.15 | 23.58 | 0.76% |